April 11, 2012

Scientists one of the Israeli universities have developed vaccine Aimed at the recognition and destruction of the human body   malignant cells . According to "Daily Telegraph", the first trials of the drug, known as "Immutsin" showed that the tool helps to fight the disease, as well as the ability to strengthen immunity   human.

The problem of the destruction of the body of cancerous cells is that such cells are not always recognized immunity. Action of a new drug aimed at a kind of "training" the body so that he could necessarily react. The target point of this reaction is protein mucin Which is on the surface of cancer cells. According to some assumptions, it is responsible for the further growth of tumors. This protein has a composition and ordinary cells, but its concentration therein is extremely small so that the reaction immunity after vaccination occurs.

Scientists believe that the drug could actually prove to be very effective in dealing with small tumors, as well as common diseases such as prostate and breast cancer. In addition, the drug will go to benefit those patients who have already undergone treatment to prevent the development of relapse .Even More doses of this drug is able to create a special immunity in all observed patients.

Further expansion of clinical trials of the drug show it is possible to use it for a number of oncological diseases . To date, the trial was attended by 10 volunteers with blood cancer. As a result, developers have stated that seven people experienced a significant increase in immunity, and three people completely cured.

Long-term tests, as well as a complicated procedure to market new drugs leads to the fact that even if the results of the most successful vaccine can be on the market only 4-6 years.